Key Highlights
- Love Collins III appointed as Vice President of Advancement at the Foundation for the National Institutes of Health (FNIH).
- Will serve as chief development officer, focusing on expanding FNIH’s biomedical research and scientific efforts.
- Extensive experience in fundraising and strategic planning, previously raising over $500 million for nonprofit sectors.
Source: Business Wire
Notable Quotes
- “[Love’s] experience in establishing trustworthy relations with research investors and philanthropists…will help catalyze the resources we need to expand the scope and impact of our scientific portfolio.” — Julie Gerberding, MD, MPH, President and CEO at FNIH
- “I am honored to be a part of the exceptionally talented team at the FNIH. The FNIH is an amazing organization, and I welcome the chance to help expand its public-private partnerships that tackle the complex health challenges that no single organization can solve on its own. Breakthroughs require resources and trustworthy relationships, and I look forward to contributing to both.” — Love Collins III, Vice President of Advancement at FNIH
SoHC's Take
The appointment of Love Collins III as the Vice President of Advancement marks a significant stride for the FNIH in enhancing its capabilities in biomedical research and philanthropy. Collins’s proven track record and strategic vision are expected to fortify FNIH’s public-private partnerships and expedite groundbreaking biomedical research, supporting NIH’s broader mission. This move underscores FNIH’s commitment to advancing global health and equity, poised to catalyze substantial developments in healthcare and science.
